Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications-Reference-Cited by-同舟云学术

Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications

Published:2020-09-12 Issue:3 Volume:35 Page:427-440
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Agarwal Shubham^ORCID,Agarwal Sanjeev Kumar^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-020-07070-1.pdf

Reference101 articles.

1. World Health Organization. Pneumonia of unknown cause — China. January 5, 2020 (https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/).

2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.

3. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–8.

4. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system-a review. [published online ahead of print, 2020 Mar 27]. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.1286.

5. Sakabe M, Yoshioka R, Fujiki A. Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis. C J Cardiol Cases. 2013;8(6):173–5. https://doi.org/10.1016/j.jccase.2013.08.002.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians;Pharmaceutics;2024-08-28

2. Evaluation of infliximab-induced genotoxicity and possible action on BCL-2 and P53 genes;Journal of Toxicology and Environmental Health, Part A;2024-06-26

3. Optimizing the Antimicrobial Effects by using Natural Compounds in COVID-19 Management;Current Medicinal Chemistry;2024-05-23

4. The effect of ritonavir on the pharmacokinetics of clonidine in vivo and in vitro;PAK J PHARM SCI;2023

5. Identification of terpenoids as potential inhibitors of SARS-CoV-2 (main protease) and spike (RBD) via computer-aided drug design;Journal of Biomolecular Structure and Dynamics;2023-08-07